Alumis (ALMS) Cash & Current Investments (2023 - 2025)
Alumis' (ALMS) quarterly Cash & Current Investments came in at $308.5 million in Q4 2025, up 7.02% year-on-year from $288.3 million in Q4 2024, and down 18.33% on a QoQ basis from $377.7 million in Q3 2025.
Alumis (ALMS) Cash & Current Investments (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Cash & Current Investments data on file, last reported at $308.5 million in Q4 2025.
- On a quarterly basis, Cash & Current Investments rose 7.02% year-over-year to $308.5 million in Q4 2025; TTM through Dec 2025 was $308.5 million, a 7.02% increase from a year earlier, with the FY2025 full-year figure at $308.5 million, up 7.02% from the prior year.
- Cash & Current Investments for Q4 2025 stood at $308.5 million, down from $377.7 million in the prior quarter.
- Over the last five years, Cash & Current Investments for ALMS reached as high as $377.7 million in Q3 2025 and fell as low as $49.0 million in Q4 2023.
- Historically, Cash & Current Investments has averaged $195.2 million across 3 years, with a median of $155.2 million in 2024.
- Across the five-year window, Cash & Current Investments jumped 566.97% in 2024 and dropped 2.0% in 2025, its largest moves.
- Year by year, Cash & Current Investments stood at $49.0 million in 2023, then soared by 488.87% to $288.3 million in 2024, then gained by 7.02% to $308.5 million in 2025.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $308.5 million in Q4 2025, $377.7 million in Q3 2025, and $152.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Alumis | 2.37 Bn | 2.06 Bn | - | 308.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 308.50 Mn |
| Sep 30, 2025 | 377.72 Mn |
| Jun 30, 2025 | 152.12 Mn |
| Mar 31, 2025 | 208.75 Mn |
| Dec 31, 2024 | 288.26 Mn |
| Sep 30, 2024 | 361.87 Mn |
| Jun 30, 2024 | 155.22 Mn |
| Mar 31, 2024 | 112.07 Mn |
| Dec 31, 2023 | 48.95 Mn |
| Sep 30, 2023 | 54.26 Mn |
| Jun 30, 2023 | 79.77 Mn |